Drugs / conventional IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02985320 Comparator | Oct 2016 → Jun 2017 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | conventional IPV | “two control groups (D and E) received three doses of conventional IPV (cIPV) or sIPV (CAMS), respectively, on the same schedule as that of test groups.” PMID 30249424 ↗ Sep 2018 |
| Known as | cIPV | “two control groups (D and E) received three doses of conventional IPV (cIPV) or sIPV (CAMS), respectively, on the same schedule as that of test groups.” PMID 30249424 ↗ Sep 2018 |
| Modality | Vaccine | “inactivated poliovirus vaccine” NCT02985320 ↗ |